Cargando…

Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”

Detalles Bibliográficos
Autor principal: Talotta, Rossella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833091/
https://www.ncbi.nlm.nih.gov/pubmed/33429060
http://dx.doi.org/10.1016/j.clim.2021.108665
_version_ 1783641985899298816
author Talotta, Rossella
author_facet Talotta, Rossella
author_sort Talotta, Rossella
collection PubMed
description
format Online
Article
Text
id pubmed-7833091
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-78330912021-01-26 Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases” Talotta, Rossella Clin Immunol Letter to the Editor Elsevier Inc. 2021-03 2021-01-08 /pmc/articles/PMC7833091/ /pubmed/33429060 http://dx.doi.org/10.1016/j.clim.2021.108665 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Talotta, Rossella
Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”
title Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”
title_full Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”
title_fullStr Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”
title_full_unstemmed Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”
title_short Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”
title_sort do covid-19 rna-based vaccines put at risk of immune-mediated diseases? in reply to “potential antigenic cross-reactivity between sars-cov-2 and human tissue with a possible link to an increase in autoimmune diseases”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833091/
https://www.ncbi.nlm.nih.gov/pubmed/33429060
http://dx.doi.org/10.1016/j.clim.2021.108665
work_keys_str_mv AT talottarossella docovid19rnabasedvaccinesputatriskofimmunemediateddiseasesinreplytopotentialantigeniccrossreactivitybetweensarscov2andhumantissuewithapossiblelinktoanincreaseinautoimmunediseases